DelOrefice Christopher has filed 21 insider transactions across 3 companies since September 2023.
Most recent transaction: a grant/award of 14363 shares of Ulta Beauty, Inc. ($ULTA) on March 31, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 31, 2026 | Ulta Beauty, Inc. | $ULTA | DelOrefice Christopher | Chief Financial Officer | A | Stock Option (right to buy) | 14363 | $0.00 | 14,363.0000 | 44,991,000 | 9999.99% | 0.03% |
| March 31, 2026 | Ulta Beauty, Inc. | $ULTA | DelOrefice Christopher | Chief Financial Officer | A | Common Stock | 4219 | $0.00 | 9,693.0000 | 44,991,000 | 77.07% | 0.01% |
| Dec. 9, 2025 | Ulta Beauty, Inc. | $ULTA | DelOrefice Christopher | Chief Financial Officer | A | Common Stock | 1825 | $0.00 | 1,825.0000 | 44,895,000 | 9999.99% | 0.00% |
| Dec. 9, 2025 | Ulta Beauty, Inc. | $ULTA | DelOrefice Christopher | Chief Financial Officer | A | Common Stock | 3649 | $0.00 | 5,474.0000 | 44,895,000 | 199.95% | 0.01% |
| Nov. 26, 2025 | BECTON DICKINSON & CO | $BDX | DelOrefice Christopher | EVP & Chief Financial Officer | F | Common Stock | 4245 | $0.00 | 22,982.0000 | 288,509,000 | 15.59% | 0.00% |
| Nov. 26, 2025 | BECTON DICKINSON & CO | $BDX | DelOrefice Christopher | EVP & Chief Financial Officer | A | Common Stock | 6006 | $0.00 | 27,227.0000 | 288,509,000 | 28.30% | 0.00% |
| Nov. 20, 2025 | RESMED INC | $RMD | DelOrefice Christopher | Director | A | ResMed Common Stock | 1073 | $0.00 | 2,423.0000 | 190,390,000 | 79.48% | 0.00% |
| Sept. 1, 2025 | BECTON DICKINSON & CO | $BDX | DelOrefice Christopher | EVP & Chief Financial Officer | F | Common Stock | 278 | $0.00 | 21,221.0000 | 288,693,000 | 1.29% | 0.00% |
| Nov. 26, 2024 | BECTON DICKINSON & CO | $BDX | DelOrefice Christopher | EVP & Chief Financial Officer | A | Common Stock | 4884 | $0.00 | 17,676.0000 | 291,009,000 | 38.18% | 0.00% |
| Nov. 26, 2024 | BECTON DICKINSON & CO | $BDX | DelOrefice Christopher | EVP & Chief Financial Officer | A | Common Stock | 9015 | $0.00 | 26,691.0000 | 291,009,000 | 51.00% | 0.00% |
| Nov. 26, 2024 | BECTON DICKINSON & CO | $BDX | DelOrefice Christopher | EVP & Chief Financial Officer | F | Common Stock | 5192 | $0.00 | 21,499.0000 | 291,009,000 | 19.45% | 0.00% |
| Nov. 26, 2024 | BECTON DICKINSON & CO | $BDX | DelOrefice Christopher | EVP & Chief Financial Officer | A | Stock Appreciation Rights | 19138 | $0.00 | 19,138.0000 | 291,009,000 | 9999.99% | 0.01% |
| Nov. 20, 2024 | RESMED INC | $RMD | DelOrefice Christopher | Director | A | ResMed Common Stock | 1083 | $0.00 | 1,350.0000 | 189,662,000 | 405.62% | 0.00% |
| Sept. 7, 2024 | BECTON DICKINSON & CO | $BDX | DelOrefice Christopher | EVP & Chief Financial Officer | F | Common Stock | 466 | $0.00 | 12,792.0000 | 290,857,000 | 3.51% | 0.00% |
| Sept. 3, 2024 | RESMED INC | $RMD | DelOrefice Christopher | Director | A | ResMed Common Stock | 267 | $0.00 | 267.0000 | 189,565,000 | 9999.99% | 0.00% |
| Sept. 1, 2024 | BECTON DICKINSON & CO | $BDX | DelOrefice Christopher | EVP & Chief Financial Officer | F | Common Stock | 254 | $0.00 | 13,258.0000 | 290,857,000 | 1.88% | 0.00% |
| Nov. 26, 2023 | BECTON DICKINSON & CO | $BDX | DelOrefice Christopher | EVP & Chief Financial Officer | A | Common Stock | 3325 | $0.00 | 14,324.0000 | 288,392,000 | 30.23% | 0.00% |
| Nov. 26, 2023 | BECTON DICKINSON & CO | $BDX | DelOrefice Christopher | EVP & Chief Financial Officer | F | Common Stock | 812 | $0.00 | 13,512.0000 | 288,392,000 | 5.67% | 0.00% |
| Nov. 26, 2023 | BECTON DICKINSON & CO | $BDX | DelOrefice Christopher | EVP & Chief Financial Officer | A | Stock Appreciation Rights | 18425 | $0.00 | 18,425.0000 | 288,392,000 | 9999.99% | 0.01% |
| Sept. 7, 2023 | BECTON DICKINSON & CO | $BDX | DelOrefice Christopher | EVP & Chief Financial Officer | F | Common Stock | 601 | $0.00 | 10,999.0000 | 0 | 5.18% | 0.00% |
| Sept. 1, 2023 | BECTON DICKINSON & CO | $BDX | DelOrefice Christopher | EVP & Chief Financial Officer | F | Common Stock | 353 | $0.00 | 11,600.0000 | 0 | 2.95% | 0.00% |